GRB2 and Alzheimer disease: Additionally, although overexpressing Grb2 could significantly reverse the effect of many AD pathologies, to our surprise in the working AD-like model, Grb2 not only failed to reduce the activity level of reactive oxygen species (ROS) but, rather, elevated it 1.27-fold [Fig. S5(i),(ii)].